Equities

TYK Medicines Inc

TYK Medicines Inc

Actions
  • Price (HKD)23.95
  • Today's Change-0.55 / -2.24%
  • Shares traded53.50k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 202320232022
ASSETS
Cash And Short Term Investments193243
Total Receivables, Net----
Total Inventory----
Prepaid expenses3328
Other current assets, total7.683.02
Total current assets234275
Property, plant & equipment, net250190
Goodwill, net----
Intangibles, net6874
Long term investments----
Note receivable - long term157.46
Other long term assets1.581.37
Total assets573558
LIABILITIES
Accounts payable329.66
Accrued expenses5123
Notes payable/short-term debt00
Current portion long-term debt/capital leases2223
Other current liabilities, total1,195906
Total current liabilities1,301962
Total long term debt2032
Total debt4256
Deferred income tax----
Minority interest4.455.19
Other liabilities, total13364
Total liabilities1,4581,064
SHAREHOLDERS EQUITY
Common stock307288
Additional paid-in capital768603
Retained earnings (accumulated deficit)(1005)(627)
Treasury stock - common----
Unrealized gain (loss)----
Other equity, total(955)(770)
Total equity(884)(506)
Total liabilities & shareholders' equity573558
Total common shares outstanding371371
Treasury shares - common primary issue00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.